Medical Marijuana and Hemp News
Medical Marijuana and Hemp News
Clinical Trial Begins for Synthetic CBD Drug Development
A Wilmington biotech firm is commencing a clinical trial for a synthetic CBD drug. Learn what this means for medicinal cannabis research, patient pathways…
CBD for Hypertension: Clinical Trial Shows Blood Pressure R…
A new clinical trial suggests CBD for hypertension may help reduce blood pressure in patients. Learn about the study published in the European Heart Journ…
Italian Medical Cannabis Trial Enrolls First Participant fo…
An Italian medical cannabis trial has enrolled its first participant, investigating a cannabis-based medicine for ALS, Parkinson's, and Alzheimer's. Learn…
Clinical Trial Explores CBD’s Impact on Liver Enzymes
A new clinical trial is investigating the potential effects of cannabidiol (CBD) on liver enzyme levels. Learn why this research is crucial for understand…
New Study Explores Cannabis for Chronic Low Back Pain Relief
A recent Phase 3 trial investigates a full-spectrum cannabis extract (VER-01) for chronic low back pain. Learn how this study suggests potential for pain…
Medicinal Cannabis Migraine Benefits: Emerging Research Ins…
Explore the emerging research on medicinal cannabis migraine benefits. Studies suggest cannabinoids may offer new avenues for managing this debilitating c…
Michael Bloch: Farewell to A Quiet Force
To our readers and visitors,
You may have noticed that things have been a bit quiet around here over the past week. It is with a heavy heart that we share the reason for this silence: our friend, colleague, and the editorial engine behind so much of what you read...
Cannabis Use Disorder: Thresholds Of THC Risk Studied
UK researchers have attempted to estimate risk thresholds for cannabis use disorder (CUD) based on delta-9-tetrahydrocannabinol (THC) consumption, using standard THC units.Cannabis use disorder is a condition whereby a person demonstrates a pattern of use that causes negative impacts in their life, but they continue to use it.The USA’s...
Study: Medical Cannabis And Driving Among Australian Patients
An Australian study looks at the impact of strict driving laws in that country on medical cannabis patients; and their attitudes towards/prevalence of driving under the influence.In most states in Australia, driving a vehicle while having any detectable level of THC in the bloodstream is illegal, regardless of lack...
Little Green Pharma And Cannatrek To Merge
Western Australian medical cannabis company Little Green Pharma (ASX:LGP) has agreed to acquire 100% of Victoria's Cannatrek's issued capital.The proposed acquisition will be implemented via a scheme of arrangement between Cannatrek and its shareholders. Shareholders of Cannatrek will be asked to approve the Scheme at a meeting expected to...
